The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be ...

Complete the form below to unlock access to ALL audio articles. In diabetes or obesity, insulin resistance in the myocardium ...

The PPARβ/δ factor is the most abundant member of the peroxisome proliferator-activated receptor (PPAR) family in the heart.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be ...

There are numerous trials revealing a blood pressure-lowering effect of thiazolidinediones in diabetic patients as well as in non-diabetic patients. Most of these studies are well designed but ...

Pre-Market: 4:22:54 a.m. EST Loading Chart for TPST ...